Impact of COVID-19 on Oncology

The coronavirus pandemic of 2019–2020 is an infectious disease caused by extreme acute respiratory coronavirus syndrome 2 (SARS‐CoV‐2). The virus primarily spread among people when they closely meet each other.
Due to the decreased immune-compromised state, cancer patients are known to be at greater risk
among community-acquired respiratory viruses such as influenza, SARS CoV-2 virus, etc. The treatment regimens of cancer such as chemotherapy, immunotherapy, and radiation therapy harm patient’s immunity making them more prone to the risk of getting infected with COVID-19 virus.
COVID-19 pandemic is impacting at every stage of cancer care i.e. screening, diagnosis, treatment,
research, and development. Through this whitepaper, we have enlighted about the effect COVID-19 virus in cancer patients.

COVID-19 has caused a tremendous shift in the medical focus concerning many other serious
diseases, including cancer. According to the American Cancer Society, more than a quarter of patients with active cancer are reporting delays in treatment. The countries where coronavirus has been increasing rapidly, many hospitals in those regions have been forced to stop such treatments.
Therefore, due to the increase in pandemic situations, many cancer patients have been finding it difficult to receive the cure. And the cancer screenings are dramatically decreased so that conditions of cancer patients did not have a negative impact while the health system diverts to fight the virus.
Countries that are most affected by this coronavirus pandemic are the United States, Brazil, Russia, Spain, Italy, United Kingdom, India, etc. It has been observed that each step in the cancer
management pathway has been disrupted by COVID-19 virus i.e. diagnosis, screening, treatment,
research, and development.

For more information you can reach us at our site iebrain dot com

Ingenious e-Brain Solutions
207-208 Welldone TechPark, Sohna Road
Sector 48, Gurugram,Haryana 122018, India
+91 124 429 4218
services@iebrain.com

Ingenious e-Brain provides high-quality, customized and cost-effective Intellectual Property Research, Business Research and Market Research solutions to industry leaders, law firms and innovative companies across the globe. Innovation, knowledge and transparency form the basis of our company’s mission and vision. Along with cost benefits, we provide highest quality patent search results ensuring fool-proof confidentiality and security. Since our inception, we have conducted patent studies covering over 100 jurisdictions. We are an ISO certified company with offices in India and USA.

This release was published on openPR.